Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.720
-0.060 (-1.26%)
May 29, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | 7.15 | 25.98 | 24.35 | 15.22 | 1.12 | |
Revenue Growth (YoY) | - | -72.50% | 6.69% | 60.05% | 1258.57% | -92.32% |
Cost of Revenue | - | 0.76 | 3.02 | 2.81 | 1.34 | - |
Gross Profit | - | 6.39 | 22.96 | 21.55 | 13.88 | 1.12 |
Selling, General & Admin | 23.3 | 29.82 | 36.75 | 44.55 | 40.18 | 18.51 |
Research & Development | 99.41 | 90.96 | 51.03 | 48.93 | 32.66 | 19.67 |
Other Operating Expenses | - | - | 2.64 | - | 3.72 | 74.16 |
Total Operating Expenses | 122.7 | 120.79 | 90.42 | 93.48 | 76.56 | 112.34 |
Operating Income | -122.7 | -114.4 | -67.46 | -71.93 | -62.68 | -111.22 |
Interest Income | 6.77 | 6.23 | 3.93 | 6.4 | 2.4 | 0.01 |
Interest Expense | - | - | -0.15 | -0.23 | -0.23 | -0.67 |
Other Non-Operating Income (Expense) | 0.13 | 87.57 | -0 | -0 | - | 1.78 |
Total Non-Operating Income (Expense) | 6.9 | 93.8 | 3.77 | 6.17 | 2.17 | 1.13 |
Pretax Income | -22.19 | -20.6 | -63.69 | -65.77 | -60.51 | -110.09 |
Provision for Income Taxes | - | - | - | - | - | -0 |
Net Income | -115.81 | -20.6 | -63.69 | -65.77 | -60.51 | -110.74 |
Net Income Attributable to Preferred Dividends | - | - | - | - | - | 0.65 |
Net Income to Common | -115.81 | -20.6 | -63.69 | -65.77 | -60.51 | -110.74 |
Shares Outstanding (Basic) | 69 | 62 | 27 | 27 | 23 | 9 |
Shares Outstanding (Diluted) | 69 | 62 | 27 | 27 | 23 | 9 |
Shares Change (YoY) | 128.57% | 128.96% | 0.42% | 19.58% | 152.27% | 250.99% |
EPS (Basic) | -1.68 | -0.33 | -2.36 | -2.44 | -2.69 | -12.41 |
EPS (Diluted) | -1.68 | -0.33 | -2.36 | -2.44 | -2.69 | -12.41 |
Shares Outstanding | 47.2 | 47.15 | 24.68 | 24.55 | 24.44 | 20.89 |
Free Cash Flow | -107.78 | -97.99 | -61.2 | -63.64 | -50.08 | -22.47 |
Free Cash Flow Per Share | -1.56 | -1.58 | -2.26 | -2.36 | -2.22 | -2.52 |
Gross Margin | - | 89.36% | 88.36% | 88.47% | 91.23% | 100.00% |
Operating Margin | - | -1601.12% | -259.62% | -295.36% | -411.94% | -9930.09% |
Profit Margin | - | -288.26% | -245.13% | -270.04% | -397.69% | -9829.46% |
FCF Margin | - | -1371.38% | -235.55% | -261.29% | -329.15% | -2006.16% |
EBITDA | -122.68 | -114.32 | -67.27 | -71.76 | -62.52 | -111.11 |
EBITDA Margin | - | -1600.01% | -258.88% | -294.67% | -410.90% | -9920.71% |
EBIT | -122.7 | -114.4 | -67.46 | -71.93 | -62.68 | -111.22 |
EBIT Margin | - | -1601.12% | -259.62% | -295.36% | -411.94% | -9930.09% |
Effective Tax Rate | - | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |